Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Global Market Report 2025
Download Free Sample Buy Now
Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Report 2025
Item added to cart!

Report Price : $4490.00

Pages : 250

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Global Market Report 2025

By Dosage Form (Oral Solids, Oral Liquids, Injectables, Topicals, Inhalation Products, Transdermal And Patches, Other Dosage Forms), By Therapeutic Area (Oncology, Cardiology, Central Nervous System, Gastroenterology, Infectious Diseases, Endocrinology ), By End-User (Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

• Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations market size has reached to $49.32 billion in 2024

• Expected to grow to $82.15 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%

• Growth Driver: The Growing Drug Development And Manufacturing Activities Is Fueling The Growth Of The Market Due To Rising Demand For Novel Therapeutics And Accelerated Production Timelines

• Market Trend: Advancement Of High-Concentration Biologic Formulation Platforms To Enhance Drug Stability And Delivery Efficiency

• Asia-Pacific was the largest region in 2024 and North America is the fastest growing region.

What Is Covered Under Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market?

A pharmaceutical contract development and manufacturing organization (CDMO) for formulations refers to a company that provides outsourced services to develop and produce drug formulations for pharmaceutical firms. These services include activities such as formulation development, analytical testing, clinical trial material production, and large-scale commercial manufacturing.

The main types of dosage forms for pharmaceutical contract development and manufacturing organizations (CDMO) for formulations are oral solids, oral liquids, Injectables, topicals, inhalation products, transdermals and patches, and others. Oral solid dosage forms are medications taken by mouth, formulated to deliver the drug within the digestive system. It is used in various therapeutic areas such as oncology, cardiology, central nervous system, gastroenterology, infectious diseases, and endocrinology, and is used by several end-users, including pharmaceutical companies, biopharmaceutical companies, and others.

Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Size and growth rate 2025 to 2029: Graph

What Is The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Size 2025 And Growth Rate?

The pharmaceutical contract development and manufacturing organization (CDMO) for formulations market size has grown rapidly in recent years. It will grow from $49.32 billion in 2024 to $54.73 billion in 2025 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to rising pharmaceutical outsourcing, increasing complexity of drug formulations, cost-saving initiatives by pharma companies, growing demand for generics and biosimilars, and expansion of small and mid-sized pharma firms.

What Is The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Growth Forecast?

The pharmaceutical contract development and manufacturing organization (CDMO) for formulations market size is expected to see rapid growth in the next few years. It will grow to $82.15 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to the surge in biologics and advanced therapies, the expansion of personalized medicine, the growing focus on continuous manufacturing, regulatory support for outsourcing, rising digitalization, and automation in manufacturing. Major trends in the forecast period include growth in continuous manufacturing, integration of AI and machine learning in drug development, expansion of high-potency API (HPAPI) handling capabilities, growing adoption of biologics and complex injectable formulations, and rising focus on sustainable and green manufacturing practices.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Segmented?

1) By Dosage Form: Oral Solids, Oral Liquids, Injectables, Topicals, Inhalation Products, Transdermal And Patches, Other Dosage Forms

2) By Therapeutic Area: Oncology, Cardiology, Central Nervous System, Gastroenterology, Infectious Diseases, Endocrinology

3) By End-User: Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Users

Subsegments:

1) By Oral Solids: Tablets, Capsules, Granules, Powders, Modified-Release Formulations

2) By Oral Liquids: syrups, Suspensions, Solutions, Emulsions, Elixirs

3) By Injectables: Vials, Ampoules, Prefilled Syringes, Lyophilized Injections, Injectable Emulsions

4) By Topicals: Creams, Ointments, Gels, Lotions, Foams,

5) By Inhalation Products: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizer Solutions, Nasal Sprays, Inhalation Capsules

6) By Transdermal And Patches: Matrix Patches, Reservoir Patches, Drug-In-Adhesive Patches, Microneedle Patches, Iontophoretic Patches

7) By Other Dosage Forms: Suppositories, Ophthalmic Preparations, Buccal Tablets, Sublingual Tablets, Implants

What Is Driving The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market? The Growing Drug Development And Manufacturing Activities Is Fueling The Growth Of The Market Due To Rising Demand For Novel Therapeutics And Accelerated Production Timelines

The growing drug development and manufacturing activities are expected to propel the growth of the pharmaceutical contract development and manufacturing organization (CDMO) for formulations market going forward. Drug development and manufacturing activities refer to the increasing efforts by pharmaceutical and biopharmaceutical companies to research, develop, and produce new drugs. Drug development and manufacturing activities are rising primarily due to the growing global demand for novel and effective therapeutics, which pushes companies to expand their development pipelines and speed up manufacturing timelines. A pharmaceutical CDMO aids drug development by formulating and optimizing dosage forms, performing stability testing, and ensuring regulatory compliance. It also manages scale-up and production, enabling faster, cost-efficient product launches. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association that represents the pharmaceutical industry in Europe, the total pharmaceutical production in Europe accounted for $422,803 million (€390,000 million) in 2023, up from $393,857 million (€363,300 million) in 2022. Therefore, growing drug development and manufacturing activities are driving the growth of the pharmaceutical contract development and manufacturing organization (CDMO) for formulations industry.

Who Are The Major Players In The Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market?

Major companies operating in the pharmaceutical contract development and manufacturing organization (cdmo) for formulations market are Thermo Fisher Scientific Inc., Lonza Group, Catalent Inc., WuXi Biologics, Samsung Biologics, Recipharm AB, Siegfried Holding AG, Evonik Industries AG, Almac Group, Aenova Group, Piramal Pharma Limited, Cambrex, Jubilant Pharmova Limited, CordenPharma, Altasciences, Hovione, Aurigene Pharmaceutical Services Ltd., DPT Laboratories Ltd., CARBOGEN AMCIS, Biopharma Group, LGM Pharma, Aarti Pharmalabs Limited.

What Are The Key Trends Of The Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market? Advancement Of High-Concentration Biologic Formulation Platforms To Enhance Drug Stability And Delivery Efficiency

Major companies operating in the pharmaceutical contract development and manufacturing organization (CDMO) for formulations market are focusing on developing advanced solutions, such as biologic formulation platforms, to enhance drug stability and accelerate time-to-market for complex biologic therapies. Biologic formulation platforms are specialized systems designed to create stable and efficient formulations of biologic drugs. They fine-tune elements such as pH, excipients, and delivery methods to enhance stability, bioavailability, and safety across the product lifecycle. For instance, in June 2025, WuXi Biologics, a China-based contract research, development, and manufacturing organization, launched WuXiHigh 2.0, a next-generation high-concentration formulation platform. This advanced platform enables biologic formulations with protein concentrations up to 230 mg/mL, surpassing the current Food and Drug Administration-approved maximum of 200 mg/mL, while reducing viscosity by up to 90% through proprietary excipient blends and high-throughput instrumentation. It addresses key challenges in developing high-concentration biologics, such as viscosity and aggregation, and is designed to improve injection efficiency, patient compliance, and manufacturing outcomes across clinical and commercial stages.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market? Jabil Acquired Pharmaceutics International Inc. (Pii) To Boost Pharmaceutical Manufacturing And Parenteral Drug Delivery Capabilities

In February 2025, Jabil Inc., a US-based provider of engineering, manufacturing, and supply chain solutions, acquired Pharmaceutics International Inc. (Pii) for an undisclosed amount. The acquisition aims to enhance Jabil’s pharmaceutical manufacturing and development capabilities by leveraging Pii’s expertise in aseptic filling, lyophilization, and oral solid dose production. This strengthens Jabil’s position in parenteral drug delivery and expands its end-to-end support across clinical and commercial manufacturing. Pharmaceutics International Inc. (Pii) is a US-based pharmaceutical contract development and manufacturing organization that provides formulation development services for injectable to oral drug forms.

What Is The Regional Outlook For The Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market?

North America was the largest region in the acute care telemedicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Acute Care Telemedicine Market?

The acute care telemedicine market includes revenues earned by entities by providing services like virtual emergency care, remote intensive care unit monitoring, tele-stroke evaluations, virtual hospitalist support, and real-time specialist consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Industry?

The pharmaceutical contract development and manufacturing organizations (CDMO) for formulations market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical contract development and manufacturing organizations (CDMO) for formulations market statistics, including the pharmaceutical contract development and manufacturing organizations (CDMO) for formulations industry global market size, regional shares, competitors with the pharmaceutical contract development and manufacturing organizations (CDMO) for formulations market share, detailed pharmaceutical contract development and manufacturing organizations (CDMO) for formulations market segments, market trends, opportunities, and any further data you may need to thrive in the pharmaceutical contract development and manufacturing organizations (CDMO) for formulations industry. This pharmaceutical contract development and manufacturing organizations (CDMO) for formulations market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Pharmaceutical Contract Development And Manufacturing Organization CDMO For Formulations Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $54.73 billion
Revenue Forecast In 2034 $82.15 billion
Growth Rate CAGR of 10.7% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered Dosage Form, Therapeutic Area, End-User, Oral Solids, Oral Liquids, Injectables, Topicals, Inhalation Products, Transdermal And Patches, Other Dosage Forms
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Thermo Fisher Scientific Inc., Lonza Group, Catalent Inc., WuXi Biologics, Samsung Biologics, Recipharm AB, Siegfried Holding AG, Evonik Industries AG, Almac Group, Aenova Group, Piramal Pharma Limited, Cambrex, Jubilant Pharmova Limited, CordenPharma, Altasciences, Hovione, Aurigene Pharmaceutical Services Ltd., DPT Laboratories Ltd., CARBOGEN AMCIS, Biopharma Group, LGM Pharma, Aarti Pharmalabs Limited.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Characteristics

3. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Trends And Strategies

4. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Growth Analysis And Strategic Analysis Framework

5.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Growth Rate Analysis

5.4. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Total Addressable Market (TAM)

6. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Segmentation

6.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Solids

Oral Liquids

Injectables

Topicals

Inhalation Products

Transdermal And Patches

Other Dosage Forms

6.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology

Cardiology

Central Nervous System

Gastroenterology

Infectious Diseases

Endocrinology

6.3. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmaceutical Companies

Biopharmaceutical Companies

Other End-Users

6.4. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Oral Solids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tablets

Capsules

Granules

Powders

Modified-Release Formulations

6.5. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Oral Liquids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Syrups

Suspensions

Solutions

Emulsions

Elixirs

6.6. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Injectables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Vials

Ampoules

Prefilled Syringes

Lyophilized Injections

Injectable Emulsions

6.7. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Topicals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Creams

Ointments

Gels

Lotions

Foams

6.8. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Inhalation Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Metered Dose Inhalers (MDIs)

Dry Powder Inhalers (DPIs)

Nebulizer Solutions

Nasal Sprays

Inhalation Capsules

6.9. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Transdermal And Patches, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Matrix Patches

Reservoir Patches

Drug-In-Adhesive Patches

Microneedle Patches

Iontophoretic Patches

6.10. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Other Dosage Forms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Suppositories

Ophthalmic Preparations

Buccal Tablets

Sublingual Tablets

Implants

7. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Regional And Country Analysis

7.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

8.1. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

9.1. China Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

9.2. China Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

10.1. India Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

11.1. Japan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

11.2. Japan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

12.1. Australia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

13.1. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

14.1. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

14.2. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

15.1. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

15.2. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

16.1. UK Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

17.1. Germany Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

18.1. France Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

19.1. Italy Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

20.1. Spain Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

21.1. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

21.2. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

22.1. Russia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

23.1. North America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

23.2. North America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

24.1. USA Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

24.2. USA Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

25.1. Canada Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

25.2. Canada Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

26.1. South America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

26.2. South America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

27.1. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

28.1. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

28.2. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

29.1. Africa Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

29.2. Africa Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Competitive Landscape And Company Profiles

30.1. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Competitive Landscape

30.2. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Company Profiles

30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Lonza Group Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Catalent Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. WuXi Biologics Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Samsung Biologics Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Other Major And Innovative Companies

31.1. Recipharm AB

31.2. Siegfried Holding AG

31.3. Evonik Industries AG

31.4. Almac Group

31.5. Aenova Group

31.6. Piramal Pharma Limited

31.7. Cambrex

31.8. Jubilant Pharmova Limited

31.9. CordenPharma

31.10. Altasciences

31.11. Hovione

31.12. Aurigene Pharmaceutical Services Ltd.

31.13. DPT Laboratories Ltd.

31.14. CARBOGEN AMCIS

31.15. Biopharma Group

32. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

34. Recent Developments In The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

35. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market High Potential Countries, Segments and Strategies

35.1 Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market In 2029 - Countries Offering Most New Opportunities

35.2 Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market In 2029 - Segments Offering Most New Opportunities

35.3 Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Oral Solids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Oral Liquids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Injectables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Topicals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Inhalation Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Transdermal And Patches, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Other Dosage Forms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Thermo Fisher Scientific Inc. Financial Performance
  • Table 82: Lonza Group Financial Performance
  • Table 83: Catalent Inc. Financial Performance
  • Table 84: WuXi Biologics Financial Performance
  • Table 85: Samsung Biologics Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Oral Solids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Oral Liquids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Injectables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Topicals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Inhalation Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Transdermal And Patches, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Other Dosage Forms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 82: Lonza Group Financial Performance
  • Figure 83: Catalent Inc. Financial Performance
  • Figure 84: WuXi Biologics Financial Performance
  • Figure 85: Samsung Biologics Financial Performance

Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Read More About Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Projected to Reach $47.74 Billion by 2029 at a CAGR of 30.7%

Read More About Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Projected to Reach $47.74 Billion by 2029 at a CAGR of 30.7%

$8.21 Billion Forecast for Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market by 2029, Backed by Demand and Innovation

Read More About $8.21 Billion Forecast for Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market by 2029, Backed by Demand and Innovation

Fentanyl Market Forecast Reaching $22.03 Billion by 2029 at 6.5% CAGR

Read More About Fentanyl Market Forecast Reaching $22.03 Billion by 2029 at 6.5% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2025 – By Type (Contract Manufacturing Services, Contract Research Services), By Research Phase (Preclinical, Phase I, Phase I...

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025 – By Product Type (Semi-Solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products), By Serv...

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025 – By Product (Gene Therapy, Cell Therapy, Tissue Engineered), By Phase (Phase I, Phase II, Phase II...

Pharmaceutical Contract Packaging Global Market Report 2025 – By Product( Primary Packaging, Secondary Packaging, Tertiary Packaging ), By Material( Paper and Paperboard, Plastics and Polymers, Aluminum Foil, Glass, Othe...

Pharmaceutical Continuous Manufacturing Global Market Report 2025 – By Product (Integrated Continuous System, Control And Software, Semi-Continuous System ), By Therapeutics Type (Large Molecule, Small Molecule), By Form...

Biopharmaceuticals Contract Manufacturing Global Market Report 2025 – By Product (Biologics, Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAi, And Molecular Therapy, Biosimilars), By Source (...

Fill-Finish Pharmaceutical Contract Manufacturing Global Market Report 2025 – By Product Type (Prefilled Syringes, Vials, Cartridges, Other Products), By Molecule Type (Large Molecules, Small Molecules), By End-User (Bio...

Pharmaceutical Logistics Global Market Report 2025 – By Type (Cold Chain Logistics, Non-Cold Chain Logistics), By Component (Storage, Transportation, Monitoring Components), By Procedure (Picking, Storage, Retrieval Syst...

Frequently Asked Questions

A pharmaceutical contract development and manufacturing organization (CDMO) for formulations refers to a company that provides outsourced services to develop and produce drug formulations for pharmaceutical firms. These services include activities such as formulation development, analytical testing, clinical trial material production, and large-scale commercial manufacturing. For further insights on the Pharmaceutical Contract Development And Manufacturing Organization CDMO For Formulations market, request a sample here

The Pharmaceutical Contract Development And Manufacturing Organization CDMO For Formulations market major growth driver - The Growing Drug Development And Manufacturing Activities Is Fueling The Growth Of The Market Due To Rising Demand For Novel Therapeutics And Accelerated Production Timelines. For further insights on the Pharmaceutical Contract Development And Manufacturing Organization CDMO For Formulations market, request a sample here

The Pharmaceutical Contract Development And Manufacturing Organization CDMO For Formulations market size has grown strongly in recent years. The pharmaceutical contract development and manufacturing organization (CDMO) for formulations market size has grown rapidly in recent years. It will grow from $49.32 billion in 2024 to $54.73 billion in 2025 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to rising pharmaceutical outsourcing, increasing complexity of drug formulations, cost-saving initiatives by pharma companies, growing demand for generics and biosimilars, and expansion of small and mid-sized pharma firms. The pharmaceutical contract development and manufacturing organization (CDMO) for formulations market size is expected to see rapid growth in the next few years. It will grow to $82.15 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to the surge in biologics and advanced therapies, the expansion of personalized medicine, the growing focus on continuous manufacturing, regulatory support for outsourcing, rising digitalization, and automation in manufacturing. Major trends in the forecast period include growth in continuous manufacturing, integration of AI and machine learning in drug development, expansion of high-potency API (HPAPI) handling capabilities, growing adoption of biologics and complex injectable formulations, and rising focus on sustainable and green manufacturing practices. For further insights on the Pharmaceutical Contract Development And Manufacturing Organization CDMO For Formulations market, request a sample here

The pharmaceutical contract development and manufacturing organization (cdmo) for formulations market covered in this report is segmented –
1) By Dosage Form: Oral Solids, Oral Liquids, Injectables, Topicals, Inhalation Products, Transdermal And Patches, Other Dosage Forms
2) By Therapeutic Area: Oncology, Cardiology, Central Nervous System, Gastroenterology, Infectious Diseases, Endocrinology
3) By End-User: Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Users Subsegments:
1) By Oral Solids: Tablets, Capsules, Granules, Powders, Modified-Release Formulations
2) By Oral Liquids: Syrups, Suspensions, Solutions, Emulsions, Elixirs
3) By Injectables: Vials, Ampoules, Prefilled Syringes, Lyophilized Injections, Injectable Emulsions
4) By Topicals: Creams, Ointments, Gels, Lotions, Foams,
5) By Inhalation Products: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizer Solutions, Nasal Sprays, Inhalation Capsules
6) By Transdermal And Patches: Matrix Patches, Reservoir Patches, Drug-In-Adhesive Patches, Microneedle Patches, Iontophoretic Patches
7) By Other Dosage Forms: Suppositories, Ophthalmic Preparations, Buccal Tablets, Sublingual Tablets, Implants For further insights on the Pharmaceutical Contract Development And Manufacturing Organization CDMO For Formulations market, request a sample here

Asia-Pacific was the largest region in the pharmaceutical contract development and manufacturing organization (CDMO) for formulations market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical contract development and manufacturing organization (cdmo) for formulations market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Pharmaceutical Contract Development And Manufacturing Organization CDMO For Formulations market, request a sample here.

Major companies operating in the pharmaceutical contract development and manufacturing organization (cdmo) for formulations market are Thermo Fisher Scientific Inc., Lonza Group, Catalent Inc., WuXi Biologics, Samsung Biologics, Recipharm AB, Siegfried Holding AG, Evonik Industries AG, Almac Group, Aenova Group, Piramal Pharma Limited, Cambrex, Jubilant Pharmova Limited, CordenPharma, Altasciences, Hovione, Aurigene Pharmaceutical Services Ltd., DPT Laboratories Ltd., CARBOGEN AMCIS, Biopharma Group, LGM Pharma, Aarti Pharmalabs Limited. . For further insights on the Pharmaceutical Contract Development And Manufacturing Organization CDMO For Formulations market, request a sample here.

Major trends in the Pharmaceutical Contract Development And Manufacturing Organization CDMO For Formulations market include Advancement Of High-Concentration Biologic Formulation Platforms To Enhance Drug Stability And Delivery Efficiency. For further insights on the Pharmaceutical Contract Development And Manufacturing Organization CDMO For Formulations market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon